|
Realtime-Estimate
Cboe BZX
16:35:19 21.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 0.8290 USD | -0.52% |
|
-7.75% | -84.90% |
| 23.09. | Compass-Therapeutics-Aktie rutscht nach Herabstufung durch Wedbush ab | MT |
| 23.09. | Compass Therapeutics, Inc. : Von Wedbush auf neutral herabgestuft | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.20% | -2.77% | -56.14% | -58.75% | -84.48% | -79.42% | -57.91% | -74.59% | - | 150 Mio. | |
| +0.79% | -6.16% | -7.71% | +18.87% | +62.91% | +49.32% | +74.50% | +5.10% | - | 66.34 Mrd. | |
| -1.06% | +5.81% | +12.86% | +9.82% | +15.17% | +10.92% | +89.07% | -17.52% | +234.99% | 52.92 Mrd. | |
| -0.10% | +4.45% | -10.21% | +2.53% | +8.73% | +7.06% | +72.85% | +206.61% | +5’209.26% | 54.82 Mrd. | |
| +0.74% | +2.75% | +0.54% | +31.36% | +18.83% | +26.31% | +45.29% | +6.49% | +259.92% | 44.09 Mrd. | |
| +3.87% | +10.15% | +9.59% | +23.80% | +26.56% | +20.69% | +132.73% | +3.19% | +1’065.86% | 43.72 Mrd. | |
| +7.91% | +4.30% | +2.93% | +8.96% | +146.77% | +263.91% | +602.72% | +629.86% | - | 42.13 Mrd. | |
| -0.40% | +9.85% | +10.03% | +14.37% | +14.51% | +17.04% | +59.17% | +9.63% | +167.54% | 33.96 Mrd. | |
| -1.30% | -0.68% | -6.79% | +27.25% | +57.12% | +37.15% | +7.04% | -56.32% | - | 26.17 Mrd. | |
| -0.31% | +4.80% | +15.04% | +40.35% | +28.27% | +35.56% | +25.42% | -11.74% | +129.07% | 23.37 Mrd. | |
| +2.20% | +2.43% | -5.09% | -1.07% | -4.23% | -15.54% | +0.29% | -66.16% | - | 22.9 Mrd. | |
| +0.40% | -1.16% | -20.27% | -10.61% | -45.03% | -43.02% | +281.46% | +258.18% | +579.96% | 20.89 Mrd. | |
| +0.45% | +2.06% | +1.65% | +17.90% | +10.82% | +14.33% | +171.51% | +230.99% | +1’913.68% | 17.37 Mrd. | |
| +2.73% | +8.20% | +10.33% | +15.96% | +46.91% | +86.42% | +205.02% | +197.55% | +448.47% | 15.95 Mrd. | |
| +2.68% | +4.16% | +3.89% | +16.42% | +29.97% | +29.76% | +72.00% | -22.02% | +90.51% | 15.41 Mrd. | |
| +1.90% | +4.98% | -1.01% | -6.92% | - | - | - | - | - | 15.39 Mrd. | |
| -1.70% | -0.86% | -2.12% | -1.70% | +172.60% | +149.75% | +358.65% | +1’398.21% | +710.15% | 14.65 Mrd. | |
| +5.14% | +5.49% | +13.45% | +43.58% | +58.14% | +71.31% | +70.14% | -25.15% | +280.06% | 15.06 Mrd. | |
| +1.11% | +8.23% | -4.52% | -7.49% | +20.65% | +0.47% | +556.77% | - | - | 14.25 Mrd. | |
| +3.60% | +5.99% | +6.14% | +4.82% | -4.41% | -7.57% | -23.17% | -36.96% | +105.58% | 13.44 Mrd. | |
| Durchschnitt | +1.42% | +3.79% | -1.37% | +9.47% | +30.52% | +35.50% | +144.40% | +146.41% | +861.16% | 27.65 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +1.39% | +4.34% | +1.03% | +14.29% | +37.70% | +44.26% | +142.86% | +127.23% | +1’188.87% |
- Börse
- Aktien
- A2QF3P Aktie
- Sektor Compass Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
